As a kidney doctor and health policy researcher, I am surprised that President Donald Trump’s initiative to remake kidney treatment has not gotten more attention. We need to keep paying attention because so much is at stake.
To lower the Part B portion of drug spending, the Trump Administration has proposed a demonstration project tying Medicare reimbursement for outpatient, physician-administered drugs to international prices. Paul Ginsburg and Steven Lieberman explore the potential consequences of such a rule.
A new analysis finds at least three quarters of the improvement in readmission rates by hospitals who had poor baseline performance was due to regression to the mean (i.e. statistical luck) rather than the policy.
Eunhae Shin, 2019 USC doctoral degree graduate and USC Schaeffer Center pre-doctoral fellow, received the 2019 Student Paper Award from the American Society of Health Economists (ASHEcon) at the society’s annual meeting in Washington, DC on June 24.
Sobin Lee and Christen Linke Young of the USC-Brookings Schaeffer Initiative estimate how effective prior-month data about the uninsured would be in predicting the number of individuals currently uninsured.